PXS-74

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePXS-74
Drug Alias Nameasthma therapeutic (Pharmaxis)leukocyte adhesion inhibitor (Pharmaxis)luukocyte migration inhibitor (Pharmaxis)PXS-74
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeukocyte adhesion inhibitorsLeukocyte migration inhibitors
TargetsUpdating
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSyntara Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSyntara Ltd
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A